New York State Common Retirement Fund Athenex, Inc. Transaction History

New York State Common Retirement Fund

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.41 - $0.91 $24,732 - $54,893	-60,323 Reduced 98.86%	698 $0
Q4 2021 Feb 02, 2022	SELL	$1.36 - $2.94 $236 - $511	-174 Reduced 0.28%	61,021 $83,000
Q3 2021 Nov 02, 2021	BUY	$2.97 - $4.84 $864 - $1,408	291 Added 0.48%	61,195 $184,000
Q2 2021 Aug 02, 2021	BUY	$3.71 - $5.13 $2,155 - $2,980	581 Added 0.96%	60,904 $281,000
Q1 2021 May 11, 2021	BUY	$4.08 - $14.75 $17,544 - $63,425	4,300 Added 7.68%	60,323 $259,000
Q3 2020 Nov 05, 2020	SELL	$10.26 - $14.55 $145,692 - $206,610	-14,200 Reduced 20.22%	56,023 $678,000
Q2 2020 Aug 07, 2020	BUY	$7.11 - $13.76 $47,800 - $92,508	6,723 Added 10.59%	70,223 $966,000
Q4 2019 Feb 05, 2020	SELL	$9.6 - $17.75 $24,000 - $44,375	-2,500 Reduced 3.79%	63,500 $970,000
Q3 2019 Nov 07, 2019	BUY	$12.16 - $21.0 $64,448 - $111,300	5,300 Added 8.73%	66,000 $803,000
Q2 2019 Aug 09, 2019	BUY	$9.44 - $19.8 $131,216 - $275,220	13,900 Added 29.7%	60,700 $1.2 Million
Q2 2018 Aug 10, 2018	BUY	$15.88 - $19.5 $627,260 - $770,250	39,500 Added 541.1%	46,800 $873,000
Q4 2017 Feb 13, 2018	BUY	$14.41 - $19.15 $105,193 - $139,795	7,300	7,300 $116,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.